Skip to main content
ITIJ

Main navigation

  • Latest
  • Magazine
  • Service Directory
  • Awards
  • Advertise
  • Subscribe

Secondary

  • Travel Insurance
  • Company News
  • Assistance & Repatriation
  • Air Ambulance
  • Travel
  • Health
  • Hospitals & Healthcare
  • Insurtech
  • General Insurance
  • Latest
  • Magazine
  • Service Directory
  • Awards
  • Advertise
  • Subscribe
  • Travel Insurance
  • Company News
  • Assistance & Repatriation
  • Air Ambulance
  • Travel
  • Health
  • Hospitals & Healthcare
  • Insurtech
  • General Insurance

Breadcrumb

  1. Home
  2. Latest
  3. Latest news
  4. TELUS donates CA$500,000 to support research into Covid-19

TELUS donates CA$500,000 to support research into Covid-19

Publishing Details

Hospitals & Healthcare

27 Mar 2020
Clara Bullock

Share

Woman doing research in lab

Canadian communications company TELUS is donating $500,000 to support a research team develop antiviral treatments for Covid-19

Keep on reading

Coroanvirus Headline

Coronavirus update: Spain’s death toll surpasses China’s, India on lockdown

Spain has joined Italy in seeing its death toll from the Covid-19 pandemic surpass that of China, while more than a billion Indians joined the lockdown confining one-third of humanity
Read More

26 Mar 2020

Clara Bullock

The donation goes to the Vancouver Prostate Centre (VPC), Vancouver General Hospital and the University of British Columbia Hospital Foundation (UBC) to assist in the research into antiviral treatments. Led by Professor Art Cherkasov, VPC and UBC scientists have joined forces with experts around the world, including collaborations with Cambridge in the UK, Memorial Sloan-Kettering in New York, University of North Carolina Pharma Science, and Enamine in Ukraine.

Research teams around the world are looking to develop vaccines, antibodies or inhibitors to fight the coronavirus. The VPC’s platforms, developed for cancer drug discovery, have been repurposed to address today’s health crisis.

Darren Entwistle, President and CEO at TELUS, said: ‘‘We are encouraged by the incredible expertise of the researchers that make up this global consortium as they rapidly search for Covid-19 treatments. As a world leader in social capitalism, it is our hope that this inaugural TELUS donation to a leading institution at the forefront of healthcare research will positively impact the lives of Canadians and of others internationally.

“As TELUS actively helps customers and citizens to support better health outcomes during this unprecedented time, we are also providing funding to bolster public healthcare capacity, enabling virtual healthcare to reduce risk of exposure, repurposing our mobile health clinics to support Covid-19 testing, and sourcing medical supplies and technology for healthcare workers.”

Dr Larry Goldenberg, Director of Development at VPC and UBC, added: “TELUS’ generous support will fast track the ability to screen this shortlist and provide British Columbia and global colleagues an enormous push towards developing an antiviral small molecule therapeutic for Covid-19 as quickly as possible. Funding will help to expand our resources including scientists, research assistants, reagents, equipment and operational costs. We encourage more organisations to help fund this vital research.”

Publishing Details

Hospitals & Healthcare

27 Mar 2020
Clara Bullock

Share

Keep on reading

CPAP UCL

UCL develops breathing aids for Covid-19 patients

Read More

30 Mar 2020

Clara Bullock

mental health

Aetna International announces partnership with wellbeing app Wysa

Read More

20 May 2020

Clara Bullock

Engage health group appoints representative

Engage Health Group appoints The Insurance Boutique as representative

Read More

25 Jun 2020

Clara Bullock

HIV medication

Access to HIV medication severely impacted by Covid-19

Read More

14 Jul 2020

Clara Bullock

ITIJ

Footer menu

  • About Us
  • Contact
  • Privacy Policy
  • Terms

Social

  • LinkedIn
  • Twitter
International Travel & Health Insurance Conferences

© Voyageur Publishing & Events 2023